Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma

NCT02124226 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Low Dose Methotrexate in Severe Chronic Asthma

Interventions

DRUG: Methotrexate
DRUG: Placebo

Sponsor

Universita degli Studi di Catania